Has Heidi Zafra received payments from drug or device companies?

Yes. Drug and device makers reported $7,033 in general payments to Heidi Zafra across 8 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Heidi Zafra did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Heidi Zafra come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Heidi Zafra

Allergy & Immunology · Milwaukee, WINPI 1245282748

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,968 of the $7,033 with a category attached, or 99.1%. 3 manufacturers reported payments, led by Biocryst Pharmaceuticals, Inc. at 43.2% of the total. Reporting peaked in 2023 at $2,025 and has fallen 59.3% since, to $825 in 2025. Among allergy & immunology clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,033in general payments, 2019–2025

Across 8 payments — averaging $879.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biocryst Pharmaceuticals, Inc.$3K
Takeda Pharmaceuticals U.S.A., Inc.$3K
Biocryst US Sales Co., LLC$1K

$308,863in research payments, 2019–2025

Across 54 payments — averaging $5719.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

GSK$90K
Biocryst Pharmaceuticals, Inc.$65K
Shire North American Group Inc$41K
Sanofi US Services Inc.$38K
AstraZeneca$36K
Astrazeneca UK Limited$20K
plus $18K from 3 others

What the payments were for

Consulting fees$6,96899%
Food & beverage$661%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biocryst Pharmaceuticals, Inc.	3	$3,038
Takeda Pharmaceuticals U.S.A., Inc.	2	$2,555
Biocryst US Sales Co., LLC	3	$1,441

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TAKHZYRO$2,555
Orladeyo$1,375

How this compares

$7,033 in reported general payments places this provider in the 90th percentile of 55 allergy & immunology providers in Wisconsin.

See all allergy & immunology providers in Wisconsin →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Montelukast Sodium	27	$212
Fluticasone Propionate	11	$130

Paid to pharmacies, not to this prescriber.

Other allergy & immunology in Milwaukee

Kelsey FinkelMilwaukee$1K
Anne LentMilwaukee$1K
Becky BuelowMilwaukee$351
Michael LevyMilwaukee$126
Asriani ChiuMilwaukee$125
Joshua SteinbergMilwaukee$71
William BusseMadison$928K
Jared DarveauxOnalaska$287K
Don BuksteinFitchburg$257K
Allan LuskinMadison$51K

See the full list for Wisconsin →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →